Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02403206
Other study ID # CTW860-P001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 26, 2015
Est. completion date August 24, 2016

Study information

Verified date June 2017
Source Alcon Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to compare femtosecond laser-assisted capsulotomy to manual capsulorhexis in patients with intumescent cataracts. An intumescent cataract is defined as a cataract with a pressurized capsular bag.


Recruitment information / eligibility

Status Completed
Enrollment 406
Est. completion date August 24, 2016
Est. primary completion date July 12, 2016
Accepts healthy volunteers No
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Willing to undergo cataract surgery.

- Able to lie flat in a supine position.

- Able to understand and willing to sign the Informed Consent Form (ICF).

- Presenting with intumescent white cataract, with a liquid pressurized bag and a milky, liquid cortex.

- Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

- Pregnant or lactating mothers.

- Corneal disease that precludes application of the cornea or transmission of laser light at 1030 nanometer (nm) wavelength.

- Corneal opacity that would interfere with the laser beam.

- Presence of blood or other material in the anterior chamber.

- Hypotony or presence of corneal implant.

- Poorly dilating pupils.

- Condition which would cause inadequate clearance between the intended capsulotomy depth and the endothelium.

- Residual, recurrent, active ocular or eye lid disease, including any corneal abnormality.

- Any contraindication to cataract surgery.

- Other protocol-specified exclusion criteria may apply.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Femtosecond laser
Laser console and a patient interface used to cut tissue during cataract removal of the crystalline lens
Procedure:
Continuous Curvilinear Capsulorhexis (CCC)
Standard-of care manual procedure (using either needles or forceps) for creating capsulorhexis, ie., opening in capsular bag during anterior segment ophthalmic surgery

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Alcon, a Novartis Company

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Capsular Tears (Anterior or Posterior) During Surgery A capsular tear is defined as any unintended tear on the anterior or posterior capsule and includes a radial tear that moves peripherally on the anterior capsule during capsulotomy and extends to form a posterior capsular tear during intumescent cataract surgery. An intumescent cataract is defined as a cataract with a pressurized capsular bag. A lower value indicates fewer capsular tears. Only one eye (study eye) contributed to the analysis. Day 0 (operative day)
Secondary Operating Time in the Eye to Complete Entire Cataract Procedure Operating time in the eye was the time interval (in seconds) from the time the corneal incision was opened to the time the wound was closed. Only one eye (study eye) contributed to the analysis. Day 0 (operative day)